Saturday 17 October 2026 Export RIGL’s income statement to Excel — free account

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $294.3 million, up 64.1% from fiscal 2024. In the quarter to June 2026, revenue fell 22.6%, EPS fell 72.1%, free cash flow fell 230.0% and total debt fell 66.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

45.97 1.28 −2.71%

Follow RIGL

Alert me

Market cap: $882.6M
P/E: 2.6×
Fwd P/E: 7.9×
Dividend yield: —
F-score: 6/9
Altman Z: 2.70
Beneish M: 0.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	2.21	1.35	2.12	4.48	+8 more quarters Free account
P/S ratio Full definition →	2.62	1.66	2.62	1.81
P/FCF ratio Full definition →	80.77	6.30	10.21	7.52
P/Operating CF Full definition →	23.66	182.70	35.05	21.26
P/B ratio Full definition →	1.71	1.25	1.97	4.35
Price to Tangible BV Full definition →	2.19	1.33	2.10	5.54
EV/Sales Full definition →	2.33	1.22	2.17	1.43
EV/EBITDA Full definition →	7.26	2.91	5.03	3.36
EV/Operating CF Full definition →	8.12	4.62	8.43	5.92
EV/FCF Full definition →	71.82	4.63	8.45	5.94
Quick Ratio Full definition →	1.58	2.20	2.08	1.94
Current Ratio Full definition →	1.94	2.62	2.42	2.28
Net Debt/EBITDA Full definition →	(3.91)	(10.70)	(5.63)	(3.75)
Debt/Assets Full definition →	0.00%	2.97%	4.38%	12.36%
Debt/Equity Full definition →	0.00	0.04	0.06	0.25
Asset Turnover Full definition →	0.76	0.88	0.87	1.48
Operating CF/Net income Full definition →	1.77	0.31	0.08	0.86
Capex/Depreciation Full definition →	(86.53)	0.00	0.00	(0.09)
Interest Coverage Full definition →	30.26	8.29	13.64	15.01
Research and Development Expense of Revenue Full definition →	17.74%	19.85%	15.31%	10.59%
Selling, General and Administrative Expense of Revenue Full definition →	41.47%	52.11%	42.97%	41.66%
Intangible Assets out of Total Assets Full definition →	0.18	0.05	0.05	0.10
Share Based Compensation of Revenue Full definition →	8.70%	5.88%	3.94%	4.84%
Graham Net Nets Full definition →	0.12	0.26	0.15	0.18
Graham Number Full definition →	95.51	99.04	99.56	30.47
Earnings Yield Full definition →	45.17%	74.22%	47.26%	22.34%
Free Cash Flow Yield Full definition →	1.24%	15.88%	9.79%	13.30%
Revenue per Share Full definition →	4.24	3.19	3.88	3.85
Operating CF per Share Full definition →	1.65	0.15	1.22	1.33
Capex per Share Full definition →	(3.79)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(2.14)	0.15	1.22	1.33
Cash per Share Full definition →	5.14	7.97	8.61	7.60
Shareholders Equity per Share Full definition →	22.94	21.72	21.76	6.52
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	22.94	21.72	21.76	6.52
Free Cash Flow Full definition →	(39.69)	2.73	21.98	24.02
Working Capital Full definition →	89.94	144.54	140.93	120.53
Capital Expenditures Full definition →	(70.35)	—	—	(0.01)
Net Current Asset Value Full definition →	89.89	129.32	118.05	90.00
EV/EBIT Full definition →	7.41	2.94	5.08	3.40
Capex to Sales Full definition →	0.89	0.00	0.00	0.00
Price to Operating Income Full definition →	8.33	4.00	6.14	4.30
Other line items
Average Receivables Full definition →	47.97	45.75	46.69	38.25
Average Payables Full definition →	5.65	4.22	5.27	3.83
Average Inventory Full definition →	12.40	8.16	8.75	9.04
Average Assets Full definition →	363.90	340.29	338.79	190.98
Average Common Equity Full definition →	253.68	209.23	197.38	51.49

Fold the line items

Columns are period end dates

Stockrow Weekly